MeSH tree: E05.200.880
A new Mount Sinai study published in the Journal of the National Cancer Institute on September 10, 2024, has found that people with lung cancer face big differences in getting important tests based on their race and income. ...
Sep 19, 2024
0
0
Over the past two decades, the United States has been transitioning from cytology to HPV-based screening for cervical cancer. The U.S. Preventive Services Task Force currently recommends one of three options for routine cervical ...
May 22, 2024
0
0
The current strategy used in Europe to mitigate malaria transfusion risk is efficient with just 10 reported cases over the 20 past years. However, current serological tests used to identify "at risk" donors are not sensitive ...
Apr 26, 2024
0
0
Nearly all cervical cancers are caused by the human papillomavirus (HPV). New evidence has led to dramatic changes in cervical cancer screening recommendations over the past 20 years.
Mar 5, 2024
0
0
Following the announcement of the WHO call to eliminate cervical cancer as a public health problem in 2020, there has been encouraging global progress in implementing and expanding Human papillomavirus (HPV) immunization, ...
Dec 14, 2023
0
0
A multidisciplinary group of tuberculosis experts from the TBnet and RESIST-TB networks have reached a consensus on key issues related to the molecular prediction of Mycobacterium tuberculosis antibiotic sensitivity or resistance ...
Apr 14, 2023
0
9
Silent but deadly. These are words often used to describe cervical cancer—a slow-growing disease that rarely causes symptoms in its early stages.
Jan 5, 2023
0
6
More than 300,000 women around the world die from cervical cancer each year. In the U.S., women of Haitian descent are diagnosed with it at higher rates than the general population.
Oct 12, 2022
0
1
